Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Felix Mehrhof

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 7, 2023
Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy-description of two casesFelix Mehrhof, Paula Bergengruen, Jin-Hong Gerds-Li, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2024
Cardiac radiotherapy transiently alters left ventricular electrical properties and induces cardiomyocyte-specific ventricular substrate changes in heart failureFelix Mehrhof, Judith Hüttemeister, Radu Tanacli, et al.
Scientific Reports|July 27, 2025
Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancerLaura Bauersachs, Marcus Beck, Christian Furth, et al.
Cardiovascular Diabetology|February 10, 2011
Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guidelineFrank Edelmann, Rolf Wachter, Hans-Dirk Düngen, et al.
Journal of Hepatology|October 11, 2012
ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosisJunfeng An, Felix Mehrhof, Christoph Harms, et al.
Radiation Oncology (London, England)|July 31, 2024
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive valueStephanie Bela Andela, Holger Amthauer, Christian Furth, et al.
Oral Oncology|February 24, 2021
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective studySebastian Zschaeck, Julian Weingärtner, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|April 20, 2021
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trialPirus Ghadjar, Wiebke Stritter, Irina von Mackensen, et al.
Heart Rhythm|August 11, 2021
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardiaDavid Krug, Oliver Blanck, Nicolaus Andratschke, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 7, 2023
Cardiac radioablation of incessant ventricular tachycardia in patients with terminal heart failure under permanent left ventricular assist device therapy-description of two casesFelix Mehrhof, Paula Bergengruen, Jin-Hong Gerds-Li, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2024
Cardiac radiotherapy transiently alters left ventricular electrical properties and induces cardiomyocyte-specific ventricular substrate changes in heart failureFelix Mehrhof, Judith Hüttemeister, Radu Tanacli, et al.
Scientific Reports|July 27, 2025
Metastasis directed radiotherapy versus standard of care for PSMA-PET diagnosed oligometastatic/oligoprogressive castration resistant prostate cancerLaura Bauersachs, Marcus Beck, Christian Furth, et al.
Cardiovascular Diabetology|February 10, 2011
Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guidelineFrank Edelmann, Rolf Wachter, Hans-Dirk Düngen, et al.
Journal of Hepatology|October 11, 2012
ARC is a novel therapeutic approach against acetaminophen-induced hepatocellular necrosisJunfeng An, Felix Mehrhof, Christoph Harms, et al.
Radiation Oncology (London, England)|July 31, 2024
Quantitative PSMA-PET parameters in localized prostate cancer: prognostic and potential predictive valueStephanie Bela Andela, Holger Amthauer, Christian Furth, et al.
Oral Oncology|February 24, 2021
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective studySebastian Zschaeck, Julian Weingärtner, Pirus Ghadjar, et al.
Radiation Oncology (London, England)|April 20, 2021
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trialPirus Ghadjar, Wiebke Stritter, Irina von Mackensen, et al.
Heart Rhythm|August 11, 2021
Recommendations regarding cardiac stereotactic body radiotherapy for treatment refractory ventricular tachycardiaDavid Krug, Oliver Blanck, Nicolaus Andratschke, et al.
Theranostics|August 8, 2024
<sup>68</sup>Ga-labeled fibroblast activation protein inhibitor (FAPI) PET/CT for locally advanced or recurrent pancreatic cancer staging and restaging after chemoradiotherapyGiulia Metzger, Christian Bayerl, Julian Mm Rogasch, et al.
Pageof 4